Minimally invasive surgery for small brain bleeds
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a less invasive surgery to remove small blood clots (20–30 ml) in the basal ganglia, a deep part of the brain. It may help people who are awake but have a reduced level of consciousness after a recent brain bleed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have had a brain bleed in the basal ganglia that started within the last 48 hours.
- The bleed is between 20 and 30 ml in size (about a small egg).
- You have a reduced level of consciousness but can open your eyes or follow commands (GCS score 9–14).
- You were able to live independently before the stroke (mRS score 0 or 1).
- Your systolic blood pressure is below 140 mmHg before the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a minimally invasive surgery (soft channel drainage) to remove a large blood clot deep in the brain after a stroke. It is for people who can have the procedure within 48 hours of bleeding and whose consciousness is reduced but not completely gone.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain caused by spontaneous bleeding. It aims to improve recovery for patients who meet specific criteria, such as clot size and time since symptoms started.
This study tests if removing a large brain clot early using a small tube and clot-dissolving medicine can improve recovery after a hemorrhagic stroke. It is for people with a moderate to large bleed who can start treatment within 12 hours of symptoms.
This study tracks patients who have had sudden, severe bleeding in the brain and received minimally invasive surgery (a less-invasive surgical approach) to treat it. Researchers want to understand outcomes and improve treatment for this serious condition.
This trial tests a non-invasive ultrasound device to help clear blood clots from the brain after a spontaneous bleed. It may be an option for people with small to medium-sized bleeds who do not need surgery.
This trial tests a minimally invasive procedure to remove deep brain bleeds using a special puncture guided by brain imaging, combined with a clot-dissolving drug called tenecteplase. It may help reduce damage from the bleed and improve recovery.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.